Evidence map›Paper›PMID 40741160›Full record

ArticlePulmonary circulation2025

Development of a Novel, Pulmonary Endovascular Device to Treat Patients With Pulmonary Hypertension.

Karl Vollmers, John Scandurra, Joshua R Woolley, Guruprasad A Giridharan, Alexander M K Rothman, Marc Pritzker, E Kenneth Weir, Christian Gerges, Irene Lang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pulmonary circulation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Karl VollmersAria CV, Inc Saint Paul Minnesota USA.
John ScandurraAria CV, Inc Saint Paul Minnesota USA.ORCID https://orcid.org/0009-0004-4014-6781
Joshua R WoolleyAria CV, Inc Saint Paul Minnesota USA.
Guruprasad A GiridharanUniversity of Louisville Louisville Kentucky USA.
Alexander M K RothmanThe University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Marc PritzkerUniversity of Minnesota Minneapolis Minnesota USA.
E Kenneth WeirUniversity of Minnesota Minneapolis Minnesota USA.
Christian GergesMedical University of Vienna Vienna Austria.ORCID https://orcid.org/0000-0002-6777-0996
Irene LangMedical University of Vienna Vienna Austria.ORCID https://orcid.org/0000-0003-0485-2692

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary hypertension (PH) carries a poor prognosis and a high mortality. Loss of pulmonary arterial compliance (PAC) plays a significant role in the development of PH and is an early predictor of mortality. Currently, there are no therapeutic options to overcome the loss of PAC. Aria CV (Saint Paul, MN) has developed a device to augment PAC. The device consists of a 20-cc balloon and anchor that can be implanted in the pulmonary artery using a minimally invasive procedure, a catheter, and a gas reservoir. Computed tomography imaging of 46 patients from the ASPIRE database and cadaver studies (

Identifiers

PMID40741160
PMCPMC12307243

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.